New obesity drug duo enters human testing
NCT ID NCT06924320
First seen Jan 21, 2026 · Last updated May 13, 2026 · Updated 28 times
Summary
This study tests whether combining two experimental drugs (MET233 and MET097) can safely help people with obesity or overweight lose weight. About 132 adults with a BMI of 27 or higher, some with type 2 diabetes, will receive either the drug combination or a placebo. The main goal is to check for side effects and measure how the drugs move through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OBESITY-RELATED MEDICAL CONDITIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site MET233/097 24-101-001
RECRUITINGCypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.